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Deep venous thrombosis prophylaxis in trauma:
Improved compliance with a novel miniaturized
pneumatic compression device
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Objective: Intermittent pneumatic compression (IPC) devices prevent lower-extremity deep venous thrombosis (LEDVT)
when used properly, but compliance remains an issue. Devices are frequently discontinued when patients are out of bed,
and they are rarely used in emergency departments. Trauma patients are at high risk for LEDVT; however, IPCs are
underused in this population because of compliance limitations. The hypothesis of this study was that a new miniaturized,
portable, battery-powered pneumatic compression device improves compliance in trauma patients over that provided by
a standard device.
Methods: This was a prospective trial in which trauma patients (mean age, 46 years; revised trauma score, 11.7) were
randomized to DVT prophylaxis with a standard calf-length sequential IPC device (SCD group) or a miniaturized
sequential device (continuous enhanced-circulation therapy [CECT] group). The CECT device can be battery-operated
for up to 6 hours and worn during ambulation. Timers attached to the devices, which recorded the time each device was
applied to the legs and functioning, were used to quantify compliance. For each subject in each location during
hospitalization, compliance rates were determined by dividing the number of minutes the device was functioning by the
total minutes in that location. Compliance rates for all subjects were averaged in each location: emergency department,
operating room, intensive care unit, and nursing ward.
Results: Total compliance rate in the CECT group was significantly higher than in the SCD group (77.7% vs. 58.9%, P 
.004). Compliance in the emergency department and nursing ward were also significantly greater with the CECT device
(P  .002 and P  .008 respectively).
Conclusions: Previous studies have demonstrated that reduced compliance with IPC devices results in a higher incidence
of LEDVT. Given its ability to improve compliance, the CECT may provide superior DVT prevention compared with that
provided by standard devices. (J Vasc Surg 2003;38:923-7.)
Intermittent pneumatic compression (IPC) devices
prevent lower-extremity deep venous thrombosis
(LEDVT) in most patient populations.1-3 Their primary
mechanism of action is an increase in venous flow velocities
in the lower extremities, which reduces the stasis compo-
nent of Virchow’s triad.4 Some evidence exists that the
devices also reduce thrombosis by increasing endogenous
fibrinolysis or by affecting other hemostatic factors.5,6 The
devices consist of sleeves that wrap around the legs or feet
and are attached to a pump. The pump causes the sleeves to
inflate, which compresses veins and ejects blood from the
legs. However, to be effective, they must be in use contin-
uously; there is no effect that lasts beyond the time they are
applied and functioning on the legs.
Compliance remains a major problem with standard
devices; the pumps require connection to an external power
source and are often discontinued when patients are out of
bed. Nursing staff may not be vigilant in ensuring that the
devices are functioning, and patients may remove the
sleeves or disconnect the devices if they find them uncom-
fortable. Additionally, IPC devices are rarely used in the
emergency department (ED) because patients travel fre-
quently for radiographic studies and other procedures. The
traditional view is that patients do not remain in the ED
long enough for development of LEDVT; however, in the
current climate of medical care, shortages of hospital beds
mean that patients often spend up to 12 hours in the ED.
DVT prophylaxis in trauma patients is a particularly
difficult problem. The risk of venous thromboembolism
(VTE) is high,7-9 and evidence suggests that a significant
number of LEDVTs and pulmonary embolisms occur very
early after injury.10 Some clinicians are uncomfortable with
the use of anticoagulants in the early period after injury
because of the risk of bleeding.11,12 The use of pneumatic
compression devices for LEDVT prophylaxis in this popu-
lation eliminates this risk.
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Recently, a new miniaturized, portable, battery-pow-
ered pneumatic compression device has been developed
(WizAir DVT Continuous Enhanced Circulation Therapy
[CECT]; Medical Compression Systems, Ltd, Or-Akiva,
Israel), which reduces the compliance problems associated
with standard devices. Inclusion of a battery allows the
CECT device to function for 5 to 7 hours without attach-
ment to an external power source. The small size and
weight (690 g) of the device allow it to be worn while
ambulating.
The hypothesis of this study was that the CECT device
would improve compliance in trauma patients over that
provided by a standard device. Improved compliance
should reduce the risk of LEDVT.
METHODS
Devices. Two pneumatic compression devices were
used in this study. One was a traditional calf-length sequen-
tial IPC device (SCD Sequential Compression Device
Model 7325 and Knee Length sleeve Model 5329; Tyco-
Kendall Manchester, Mass; SCD group), which requires
attachment to an external power source to function. The
second was a miniaturized, battery-powered sequential de-
vice (WizAir DVT Continuous Enhanced Circulation
Therapy, Calf sleeve Model 201-C-1; Medical Compres-
sion Systems Inc;. CECT group) weighing 690 g, which
can function from an internal battery for up to 6 hours. The
device recharges when attached to an external power source
with an AC adapter; throughout the study, the device was
recharged in this fashion. The internal batteries were not
changed during the study.
The compression profiles for the two devices are simi-
lar: the SCD system uses 11 seconds of compression fol-
lowed by 60 seconds of decompression, and a maximum
pressure during inflation of 50 mm Hg. The CECT device
uses 8 seconds of compression followed by 52 seconds of
decompression, and an average maximum sleeve pressure
during inflation of 50 mm Hg. The pumping characteristics
of the two devices, measured as increases in popliteal and
femoral peak systolic venous flow velocities, are similar
(Table I).
Protocol. This protocol was approved by the Institu-
tional Review Board at The University of Texas Medical
Branch (UTMB), and informed consent was obtained from
all study participants before enrollment. Trauma patients
were enrolled upon arrival to the ED. Eligible subjects
included those who experienced motor vehicle accidents,
penetrating trauma, hip fractures, spinal cord injuries, and
head injuries. All participants were projected to remain
hospitalized for 12 hours and to be able to have IPC
devices applied to both legs, and had no history of venous
thromboembolism or requirement for systemic anticoagu-
lation. Only adult subjects (18 years) were eligible. Sub-
jects were randomized to treatment with the SCD or the
CECT device, and compression was begun immediately
after randomization. Counters were affixed to the devices
to monitor the amount of time the device was applied and
pumping. Nursing staff and physicians were educated re-
garding the use of the two devices before initiation of the
study. They were instructed to use the devices whenever
possible according to protocols already in place at UTMB,
which include attaching the SCD device to a power source
when possible and using the battery function of the CECT
device at all times when necessary. Devices were monitored
at least two times daily to ensure the timers were function-
ing, but no attempts by the study investigators were made
to influence the use of the devices once the patient was
enrolled in the study. All other aspects of patient care,
including the decision to use low-dose unfractionated or
low–molecular weight heparin for additional LEDVT pro-
phylaxis, were at the discretion of the treating physician.
Enrollment in the study ended at the time of hospital
discharge or diagnosis of VTE.
Total compliance was quantified as the ratio of the total
number of minutes each device was pumping on a subject
divided by the total number of minutes the subject was
enrolled. For each subject, a percentage was calculated by
multiplying the ratio by 100; data for all subjects in each
Table I. Venous flow velocities* generated by study devices
SCD† CECT†
P‡
Maximal vs
baseline
SCD vs
CECT
Common femoral
venous velocity,
cm/sec
Baseline 13.07  3.79 13.63  5.36 .001 .006§
Maximal 16.38  3.41 19.34  6.78
Popliteal venous
velocity, cm/sec
Baseline
Maximal
8.05  2.01
19.97  4.66
8.67  3.13
22.40  11.37
.001 .54
The exclusion criteria included a history of thromboembolism. All subjects were examined in the supine position.
N  10 (healthy volunteers), 5 men and 5 women, mean age 34.4  6.1 years.
*Measured with duplex ultrasound scanner by using a linear 7.5-MHz transducer.
†Data expressed as mean  SEM.
‡ANOVA with repeated measures.
§CECT achieved significantly higher femoral venous velocity than SCD.
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group were pooled. Compliance rates for each device in
each site (ED, operating room [OR], intensive care unit
[ICU], nursing ward [WARD]) were also calculated.
Transportation minutes were added to the site to which the
patient was moving.
Statistical analysis. All data were expressed as mean
SEM. The proportional characteristics of the two groups
were compared with the Fisher exact test for frequencies
and the independent Student t test for continuous data.
The compliance rates were analyzed with the independent
Student t test or a-parametric test (Mann-Whitney U test)
when the values were not characterized by normal distribu-
tion. P values were assessed at the .05 level of significance.
RESULTS
Subjects. Thirty three subjects completed the study.
The mean age, sex, time until enrollment, total enrollment,
revised trauma score, the use of pharmacologic prophylaxis,
and frequencies of patient locations for each group are
summarized in Table II. Types of traumatic injuries are
summarized in Table III. There were no significant differ-
ences in age or sex between the two groups (P  .40 and
P  .73, respectively). The time from arrival in the ED to
enrollment was slightly longer in the CECT group, but the
difference between the two groups was not statistically
significant (P .06). The total enrollment time was similar
between the two groups (P  1.00). The revised trauma
score was not statistically different between the two groups
(P  .94), nor were the types of traumatic injuries experi-
enced by the patients (P  .398). Additional pharmaco-
logic prophylaxis (low-dose unfractionated or low–molecu-
lar weight heparin) was not statistically different between
the two groups (P 1.00), nor were frequencies of patient
locations (P .77). There were no significant differences in
the mechanisms of injury (Table III, P  .54). No subject
developed signs or symptoms of venous thromboembolism
during the study.
Compliance rates. Total compliance rate in the
CECT group was significantly higher than in the SCD
group (P .004, Table IV). It was also significantly higher
in the ED (P .002) and in the WARD (P .008). There
was a trend toward higher compliance in the OR with the
CECT, but this did not reach statistical significance (P 
.28). There was no statistically significant difference be-
tween the groups in the ICU (P  .99).
DISCUSSION
Compliance remains the most significant problem as-
sociated with the use of IPC devices for prevention of
LEDVT. The devices currently in widespread use require
attachment to an external power source to function, and
they are frequently not functioning when patients are out of
bed or being transported. This problem was first noted by
Comerota et al in 1992,13 who reported that patients
residing on routine nursing units at their institution were
wearing “properly functioning” IPC devices only 48% of
the time. More recently Haddad et al14 reported an overall
compliance rate of 78% in 79 patients undergoing elective
total hip arthroplasties. In 227 trauma patients, Cornwell et
Table II. Patient characteristics
SCD CECT P
Number of subjects 16 17
Age (mean  SEM, years) 51.4  5.3 45.4  4.7 0.404*
Sex (M:F) 9:7 11:6 0.728†
Time until enrollment (mean 
SEM, minutes)
126  19 186  24 0.058*
Total enrollment (mean  SEM,
minutes)
7090  2008 7089  1563 1.000*
Revised trauma score 11.75  0.11 11.76  0.16 0.941*
Use of additional pharmacologic
prophylaxis (%)
18.8 23.5 1.000*
0.772†
Frequencies of patient locations
(No. of subject, %)
ED 12 (75) 11 (65)
OR 4 (25) 7 (41)
ICU 8 (50) 12 (71)
WARD 16 (100) 17 (100)
ED, Emergency department; OR, operating room; ICU, intensive care unit; WARD, nursing ward.
*Independent student t test.
†Fisher exact test.
Table III. Type of traumatic injury
No. of subjects (%)
P*SCD CECT
Head injury 3 (19) 3 (18) .398
Spinal cord injury 1 (6) 1 (6)
Pelvic injury 4 (25) 1 (6)
Lower-extremity injury 1 (6) 5 (29)
Chest injury 1 (6) 3 (18)
Abdominal injury 3 (19) 1 (6)
Others 3 (19) 3 (18)
*Fisher exact test.
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al15 reported that IPC devices were applied and functioning
only 53% of the time (712 of 1343 observations). More-
over, all three groups stated that education of nursing and
other staff did not improve compliance rates.13-15
Because the amount of time IPC devices are function-
ing is directly related to the prevalence of LEDVT, compli-
ance is essential. Westrich and Sculco16 studied the efficacy
of IPC devices in preventing DVT in 122 patients under-
going total knee replacement. Overall, 27% of patients
treated with IPC  aspirin developed LEDVT. However,
in patients in whom DVT developed, devices were applied
and functioning only 13.4 4.3 hours per day (56% of the
time), whereas those in whom no DVT developed were
wearing devices 19.2  5.1 hours per day (80% of the
time). Interestingly, ward compliance rates reported in the
studies of Comerota et al (48%)8 and Cornwell et al
(53%),10 as well as the SCD group in this study (59%), are
similar to the group in Westrich’s11 study in whom DVT
occurred. These findings suggest that to achieve LEDVT
prevention, compliance rates must be improved. In this
study, use of the CECT device resulted in a compliance rate
(78%) similar to the group in Westrich’s11 study in whom
no DVT developed (80%).
Achieving higher compliance rates with IPC will re-
quire development of new devices that overcome the limi-
tations of the current generation of devices. These limita-
tions include the requirement for attachment to an external
power source and weight, both of which result in discon-
tinuation of pumping when the patient leaves the hospital
bed. Even assuming high-quality nursing care, the cur-
rently available devices cannot be used when the patient is
being transported or is located in areas where power
sources are unavailable. Also, they cannot be used when the
patient is bathing or ambulating.
By virtue of its design features, the CECT device eval-
uated in this study eliminates many of the issues contribut-
ing to poor compliance rates with pneumatic compression
devices. The CECT is small and light (690 g) and is able to
operate from a battery for up to 7 hours, which means that
it can be in use at virtually all times other than when a
patient is bathing. If the patient is transported to a different
location, the device can be detached from the power source
and the pump will continue to function during transport.
Because it weighs very little, patients can carry it, which
makes it less likely to be removed when the patient ambu-
lates. Indeed, in this study, significantly higher compliance
rates were found with the CECT group (78%) compared
with the SCD group (59%).
Compliance rates in the CECT group were also signif-
icantly higher than in the SCD group in the ward and in the
ED, but not in the ICU. The higher compliance rates
observed in the ED with the CECT most likely occurred
because patients were transported to radiologic procedures
during this period. During transport, the SCD does not
operate, whereas the CECT continues to operate from the
internal battery. The equivalent compliance observed in the
ICU is most likely related to the higher nursing acuity in
this location.
There was a trend toward improved compliance in the
OR in CECT group, but this did not reach statistical
significance. There are two possible explanations for this
finding. The first is that the compliance rate with the CECT
may truly be higher, but we were unable to demonstrate
this because of the small number of patients in this study
who underwent operative procedures. Because the SCD
device requires attachment to an external power source,
staff may forget to turn it on during operative procedures,
although the sleeves are applied to the patient. The second
is that there may be no difference in compliance rates
between the two devices in this environment. Determina-
tion of the correct explanation will require a larger study.
Trauma patients were chosen as study subjects in this
investigation because of their high risk of DVT and because
providing good quality DVT prophylaxis is difficult. With-
out prophylaxis, patients with major trauma experience
DVT at a rate exceeding 50%.17,18 However, of the two
readily available methods of prophylaxis, pneumatic com-
pression devices are frequently impractical and anticoagu-
lants can result in unacceptable bleeding. In one study,
anticoagulants were “contraindicated” in 46% of trauma
patients.11 Other clinicians have recommended delaying
administration of anticoagulants in trauma patients for 24
to 36 hours after injury because of the risk of bleeding.19
These findings demonstrate the difficulty in providing
effective DVT prophylaxis during the early period after
trauma; yet evidence exists that venous thromboembolism
can develop during this period. Owings et al10 studied the
timing of the occurrence of pulmonary embolism (PE) in
63 trauma patients, and they found that 6% occurred dur-
ing the first day of hospitalization, 6% occurred during day
Table IV. Compliance rate
Group n
Compliance, %
ED (n) OR (n) ICU (n) WARD (n) Total (N)
SCD 16 57.8  10.5 (12) 22.1  22.1 (4) 69.9  12.5 (8) 46.0  7.2 (16) 58.9  4.6
CECT 17 100.0  0.0 (11) 57.1  20.2 (7) 70.1  10.8 (12) 72.8  6.1 (17) 77.7  3.9
P value 0.002* 0.28* 0.99* 0.008† 0.004†
ED, Emergency department; OR, operating room; ICU, intensive care unit; WARD, nursing ward.
*Mann-Whitney U test.
†Independent student t test.
All data are expressed as mean  SEM.
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2, and overall 25% occurred during the first 4 days. Reduc-
ing the rate of VTE in trauma patients will require a method
of prophylaxis that can be initiated in the ED. The data
presented here suggest that the CECT device may be the
best method in this setting.
Given its ability to improve compliance, the CECT may
provide superior DVT prevention compared with that pro-
vided by standard devices. However, final proof of the
improved efficacy of the CECT will require a larger study in
which DVT rates are quantified. Such a study is currently
underway in our institution. In the interim, the results of
this study also suggest that the CECT device can be used
effectively in hospital environments such as the ED where
IPC devices have not traditionally been used
The authors gratefully acknowledge the technical sup-
port of Sarit Gelbart.
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